AVIS BUDGET GROUP, INC. Logo

AVIS BUDGET GROUP, INC.

Global provider of car rental, truck rental, and car-sharing for business & leisure travelers.

CAR | US

Overview

Corporate Details

ISIN(s):
US0537741052
LEI:
Country:
United States of America
Address:
379 INTERPACE PARKWAY, 7054 PARSIPPANY
Sector:
Mining and quarrying
Industry:
Mining of non-ferrous metal ores

Description

Avis Budget Group, Inc. is a leading global provider of mobility solutions. The company operates through its three primary brands: Avis, a premium car rental service; Budget, a value-focused car and truck rental provider; and Zipcar, a prominent car-sharing network. Serving a diverse customer base of business and leisure travelers, the company manages a vast network of approximately 10,250 rental locations. With a history dating back to 1946, Avis Budget Group focuses on advancing the future of mobility through investments in connected vehicle technology, sustainable and electric fleet options, and strategic partnerships.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all AVIS BUDGET GROUP, INC. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for AVIS BUDGET GROUP, INC.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for AVIS BUDGET GROUP, INC. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Nuvectis Pharma, Inc. Logo
Clinical-stage biopharma developing precision medicines for serious oncological conditions.
United States of America
NVCT
Nykode Therapeutics ASA Logo
Developing novel immunotherapies and vaccines for cancer with its antigen-targeting platform.
Norway
NYKD
Ocugen, Inc. Logo
Develops gene/cell therapies and vaccines, specializing in blindness and public health.
United States of America
OCGN
Oculis Holding AG Logo
Clinical-stage biopharma developing non-invasive eye drops for sight-threatening diseases.
Switzerland
OCS
OKYO Pharma Ltd Logo
Biopharma developing novel drugs for inflammatory eye diseases and neuropathic corneal pain.
United States of America
OKYO
OLIPASS CORPORATION Logo
Biotech firm developing RNA therapeutics for diseases with its proprietary OPNA platform.
South Korea
244460
A technology platform for pharma/biotech to discover therapeutic antibodies via transgenic animals.
United States of America
OABIW
Oncocross Co.,Ltd. Logo
AI-powered biotech accelerating drug development for cancer and rare diseases.
South Korea
382150
Onconic Therapeutics Inc. Logo
Develops novel drugs for cancer and GI diseases, including a next-gen acid blocker.
South Korea
476060
OncoTherapy Science, Inc. Logo
Develops targeted cancer therapies and provides TCR repertoire analysis services.
Japan
4564

Talk to a Data Expert

Have a question? We'll get back to you promptly.